4//SEC Filing
Prince Joshua S. 4
Accession 0001415889-25-018202
CIK 0001411685other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 5:15 PM ET
Size
5.9 KB
Accession
0001415889-25-018202
Insider Transaction Report
Form 4
Prince Joshua S.
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-06-23+100,000→ 100,000 totalExercise: $1.96Exp: 2035-06-23→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Represents stock options (the "Options") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the "Grant Date"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date.
Documents
Issuer
Vistagen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001998663
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 5:15 PM ET
- Size
- 5.9 KB